Business Wire

Global Silicone Based Catheters Markets Report 2021-2022 & 2028: Rapid Adoption of Single-Use Catheters and Self-Catheterization – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Silicone Based Catheters Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Application, Usage, Tip, Product Type, Type and End User” report has been added to ResearchAndMarkets.com’s offering.

Urinary Tract Infection (UTI)/Catheter Acquired Urinary Tract Infection (CAUTI) Segment to Hold Largest Share of Silicone Based Catheters Market During 2021-2028

The market is projected to reach US$ 240.91 million by 2028 from US$ 150.87 million in 2021 and is expected to grow at a CAGR of 6.9% from 2021 to 2028.

As per the National Center for Biotechnology Information (NCBI) report, the COVID-19 pandemic has a significant impact on the global health economies. The impact of the pandemic hindered the growth for the overall market as the adoption of silicone based catheters among healthcare facilities was reduced. Silicone based catheters are generally used in urinary tract infection and prostate gland surgeries practices.

However, most of these procedures were halted due to the emergence of COVID-19 crisis. According to a research conducted by the Commonwealth Fund report, during the first week of April and May 2020, the hardest-hit medical specialties such as dental, ophthalmology, ENT, and dermatology experienced a strong decline beyond 50%. With COVID-19 lockdowns, all UTI and prostate surgeries stopped.

Thus, foley catheter-based treatments experienced the strongest decline in terms of procedures performed in hospitals. For instance, in March 2020, the UK introduced a country-wide lockdown that came into effect from March 23rd, 2020.

Since then, clinics offering laser and intense pulsed light services have remained closed for business. With a strategy to relax, COVID-19 lockdown has been discussed and implemented worldwide with vaccination drive proving helpful, many foley catheters practitioners have resumed their silicone based catheters services.

Based on application, the silicone based catheters market is segmented into urinary tract infection (UTI)/catheter acquired urinary tract infection (CAUTI), surgery on contiguous structures of the genitourinary tract, prostate gland surgery, spinal cord injury, and others.

The urinary tract infection (UTI)/catheter acquired urinary tract infection (CAUTI) segment held the largest share in 2021 and is expected to continue a similar trend during the forecast period. On the other hand, the prostate gland surgery segment held the second largest share of the market in 2020 and is projected to continue its dominance during the forecast period.

The catheters are mainly used to monitor the urine production by kidney and in case of urinary incontinence. Most UTIs in women are acute uncomplicated cystitis caused by Escherichia coli (86%), Staphylococcus saprophyticus (4%), Klebsiella species (3%), Proteus species (3%), Enterobacter species (1.4%), Citrobacter species (0.8%), or Enterococcus species (0.5%). Thus, the rising prevalence of UTI propels the demand for catheters, which fuels the growth of the silicone based catheter market.

Key Market Dynamics

Market Drivers

  • Growing Prevalence of Urinary Incontinence
  • Increasing Surgical Procedures

Market Restraints

  • Alternatives to Treatment of Urinary Incontinence

Market Opportunities

  • Increasing Medical Tourism

Future Trends

  • Rapid Adoption of Single-Use Catheters and Self-Catheterization

Company Profiles

  • Teleflex Incorporated
  • B. Braun Melsungen AG
  • Convatec Group plc
  • Ribbel International Limited
  • Bactiguard
  • Bd
  • Cook Medical LLC
  • Angiplast
  • Sterimed Group
  • Mais India
  • Medasil Surgical Limited

For more information about this report visit https://www.researchandmarkets.com/r/6sg243

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Comment moderation is enabled. Your comment may take some time to appear.

Back to top button

Adblock detected

Please consider supporting us by disabling your ad blocker